54,115
Participants
Start Date
October 22, 2014
Primary Completion Date
July 6, 2024
Study Completion Date
July 6, 2024
Assessment of body temperature
Axillary body temperature of all participants recorded by a digital thermometer at the time of survey.
Blood sampling
Capillary blood samples collected by finger/heel prick for determination of parasite prevalence at the time of survey.
GSK Investigational Site, Ouagadougou
GSK Investigational Site, Dakar
GSK Investigational Site, Dakar
GSK Investigational Site, Kisumu
GSK Investigational Site, Nairobi
GSK Investigational Site, Kisumu
GSK Investigational Site, Nouna
GSK Investigational Site, Kintampo
GSK Investigational Site, Navrongo
GSK Investigational Site, Chikwawa
GSK Investigational Site, Mangochi
GSK Investigational Site, Amani
Lead Sponsor
The PATH Malaria Vaccine Initiative (MVI)
OTHER
GlaxoSmithKline
INDUSTRY